Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02844439
Title Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kadmon Corporation, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Center for Neurosciences Tucson Arizona 85718 United States Details
City of Hope Duarte California 91010 United States Details
University of California, San Francisco (UCSF) San Francisco California 94143 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Columbia University, Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
UT MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field